SEARCH OUR PRODUCT CATALOG

SEMA3C-CD36 Fusion FISH Probe

The SEMA3C-CD36 Fusion FISH Probe is used to confirm a fusion of the SEMA3C and CD36 genes. The fusion of the SEMA3C and CD36 genes has been associated with Lung Squamous Cell Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.

** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.

Turnaround Time: 7-10 Business Days    Shipping Time: 1-2 Day Expedited Shipping

SKU Test Kits Buffer Dye Color Order Now
SEMA3C-CD36-20-ORGR  (Standard Design) 20 (40 μL) 200 μL
SEMA3C-CD36-20-RERE 20 (40 μL) 200 μL
SEMA3C-CD36-20-REOR 20 (40 μL) 200 μL
SEMA3C-CD36-20-REGO 20 (40 μL) 200 μL
SEMA3C-CD36-20-REGR 20 (40 μL) 200 μL
SEMA3C-CD36-20-REAQ 20 (40 μL) 200 μL
SEMA3C-CD36-20-ORRE 20 (40 μL) 200 μL
SEMA3C-CD36-20-OROR 20 (40 μL) 200 μL
SEMA3C-CD36-20-ORGO 20 (40 μL) 200 μL
SEMA3C-CD36-20-ORAQ 20 (40 μL) 200 μL
SEMA3C-CD36-20-GORE 20 (40 μL) 200 μL
SEMA3C-CD36-20-GOOR 20 (40 μL) 200 μL
SEMA3C-CD36-20-GOGO 20 (40 μL) 200 μL
SEMA3C-CD36-20-GOGR 20 (40 μL) 200 μL
SEMA3C-CD36-20-GOAQ 20 (40 μL) 200 μL
SEMA3C-CD36-20-GRRE 20 (40 μL) 200 μL
SEMA3C-CD36-20-GROR 20 (40 μL) 200 μL
SEMA3C-CD36-20-GRGO 20 (40 μL) 200 μL
SEMA3C-CD36-20-GRGR 20 (40 μL) 200 μL
SEMA3C-CD36-20-GRAQ 20 (40 μL) 200 μL
SEMA3C-CD36-20-AQRE 20 (40 μL) 200 μL
SEMA3C-CD36-20-AQOR 20 (40 μL) 200 μL
SEMA3C-CD36-20-AQGO 20 (40 μL) 200 μL
SEMA3C-CD36-20-AQGR 20 (40 μL) 200 μL
SEMA3C-CD36-20-AQAQ 20 (40 μL) 200 μL

CD36 Gene Summary

The protein encoded by this gene is the fourth major glycoprotein of the platelet surface and serves as a receptor for thrombospondin in platelets and various cell lines. Since thrombospondins are widely distributed proteins involved in a variety of adhesive processes, this protein may have important functions as a cell adhesion molecule. It binds to collagen, thrombospondin, anionic phospholipids and oxidized LDL. It directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes and it binds long chain fatty acids and may function in the transport and/or as a regulator of fatty acid transport. Mutations in this gene cause platelet glycoprotein deficiency. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Feb 2014]

Gene Name: CD36 Molecule

Chromosome: CHR7: 80231503 -80303734

Locus: 7q21.11

SEMA3C Gene Summary

This gene encodes a secreted glycoprotein that belongs to the semaphorin class 3 family of neuronal guidance cues. The encoded protein contains an N-terminal sema domain, integrin and immunoglobulin-like domains, and a C-terminal basic domain. Homodimerization and proteolytic cleavage of the C-terminal propeptide are necessary for the function of the encoded protein. It binds a neuropilin co-receptor before forming a heterotrimeric complex with an associated plexin. An increase in the expression of this gene correlates with an increase in cancer cell invasion and adhesion. Naturally occurring mutations in this gene are associated with Hirschsprung disease. [provided by RefSeq, May 2017]

Gene Name: Semaphorin 3C

Chromosome: CHR7: 80371853 -80548667

Locus: 7q21.11

Gene Diseases

The SEMA3C CD36 Fusion has been associated with the following diseases:

Disease Name
Lung Squamous Cell Carcinoma

FISH Probe Protocols

Protocol, Procedure, or Form Name Last Modified Download

Method for the Prognosis of Multiple Myeloma

Although survival rates have improved significantly in the past decade, multiple myeloma is still considered largely incurable. This patent aims to identify genetic biomarkers specific to MM that could serve as potential prognostic indicators. The authors propose using gene expression values of four CD markers - CD24, CD27, CD36 and CD302 – to predict clinical outcome in MM. The team suggests Empire Genomics’ CD36 and CD302 FISH probes for detection of these genes.